Wrapping hydroxyapatite orbital implants with posterior auricular muscle complex grafts

被引:31
作者
Naugle, TC
Lee, AM
Haik, BG
Callahan, MA
机构
[1] Tulane Univ, Med Ctr, Dept Ophthalmol, New Orleans, LA USA
[2] Univ Tennessee, Dept Ophthalmol, Memphis, TN USA
[3] Univ Alabama, Dept Ophthalmol, Birmingham, AL 35294 USA
关键词
D O I
10.1016/S0002-9394(99)00159-2
中图分类号
R77 [眼科学];
学科分类号
100212 ;
摘要
PURPOSE: To report the use of posterior auricular muscle complex grafts as a wrapping material for hydroxyapatite orbital implants in enucleation surgery. METHOD: In a retrospective multicenter study, autogenous posterior auricular muscle complex grafts were used to cover hydroxyapatite orbital implants in 83 patients with a mean age of 38.6 years (range, 1 to 85 years), of whom 63 had primary unilateral enucleation and 20 had secondary orbital implants following enucleation. The mean follow-up period after posterior auricular muscle complex grafts was 36 months (range, 14 to 60 months). RESULTS: Of the 83 patients, two (2.4%) developed limited orbital implant exposure, which was treated with a second posterior auricular muscle complex "patch graft." No patient developed postoperative orbital infection or implant extrusion. All patients were fitted with an acceptable prosthesis and had satisfactory cosmetic and functional results. No patient developed vascular com promise or a wound defect associated with the posterior auricular donor site. CONCLUSION: Autogenous posterior auricular muscle complex grafts should be considered as an appropriate wrapping material for hydroxyapatite orbital implants for primary enucleation and for secondary orbital implants after enucleation. (Am J Ophthalmol 1999;128:495-501. (C) 1999 by Elsevier Science Inc. All rights reserved.).
引用
收藏
页码:495 / 501
页数:7
相关论文
共 15 条
[1]  
ANSON NJ, 1973, SURG ANATOMY TEMPORA, P191
[2]   TISSUE BREAKDOWN AND EXPOSURE ASSOCIATED WITH ORBITAL HYDROXYAPATITE IMPLANTS [J].
BUETTNER, H ;
BARTLEY, GB .
AMERICAN JOURNAL OF OPHTHALMOLOGY, 1992, 113 (06) :669-673
[3]  
DUTTON JJ, 1991, OPHTHALMOLOGY, V98, P370
[4]  
GOLDBERG RA, 1992, OPHTHALMOLOGY, V99, P831
[5]   Rate of vascularization of coralline hydroxyapatite spherical implants pretreated with saline/gentamicin, rTGF-β2, and autogenous plasma [J].
Holck, DEE ;
Dutton, JJ ;
Proia, A ;
Khawly, J ;
Mittra, R ;
Dev, S ;
Imami, N .
OPHTHALMIC PLASTIC AND RECONSTRUCTIVE SURGERY, 1998, 14 (02) :73-80
[6]  
Mustarde J C, 1978, Clin Plast Surg, V5, P459
[7]  
NAUGLE TC, 1988, OPHTHAL PLAST RECONS, V4, P127
[8]  
NAUGLE TC, 1997, OPHTHALMOLOGY, V104, P480
[9]  
Perry A C, 1990, Adv Ophthalmic Plast Reconstr Surg, V8, P75
[10]  
REMULLA HD, 1995, OPHTHALMOLOGY, V102, P586